2022
An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva
Li JY, Arkfeld CK, Tymon-Rosario J, Webster E, Schwartz P, Damast S, Menderes G. An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva. Journal Of Gynecologic Oncology 2022, 33: 0. PMID: 34910394, PMCID: PMC8899873, DOI: 10.3802/jgo.2022.33.e13.Peer-Reviewed Original ResearchConceptsDisease-specific survivalSquamous cell carcinomaOverall survivalPositive marginsCell carcinomaNodal involvementPrognostic factorsStage IFive-year disease-specific survivalPrimary squamous cell carcinomaRecurrent squamous cell carcinomaFive-year RFSNode-positive patientsVulvar cancer patientsEscalation of treatmentConservative surgical approachKaplan-Meier estimatesLog-rank testCox proportional hazardsLocal RFSOverall RFSAdjuvant radiotherapyDistant recurrenceFree survivalMedian survival
2016
Treatment of early stage vaginal cancer with EBRT and MRI-based intracavitary brachytherapy: A retrospective case review
Damast S, Takiar V, McCarthy S, Higgins SA. Treatment of early stage vaginal cancer with EBRT and MRI-based intracavitary brachytherapy: A retrospective case review. Gynecologic Oncology Reports 2016, 17: 89-92. PMID: 27536721, PMCID: PMC4975702, DOI: 10.1016/j.gore.2016.08.002.Peer-Reviewed Original ResearchPrimary vaginal cancerIntracavitary brachytherapyPelvic radiotherapyVaginal cancerTumor thicknessLocal failure-free survivalLong-term clinical outcomesEarly stage vaginal cancerLate grade 3Non-bulky tumorsFailure-free survivalFIGO stage IDisease-specific survivalTerm clinical outcomesTime of diagnosisRetrospective case reviewSeries of patientsInitial tumor volumeTime of brachytherapyInitial tumor thicknessMedian followOverall survivalPartial responseRT doseComplete response